A detailed history of Sphera Funds Management Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 56,504 shares of DYN stock, worth $1.35 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
56,504
Holding current value
$1.35 Million
% of portfolio
0.37%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.94 - $47.04 $1.8 Million - $2.66 Million
56,504 New
56,504 $2.03 Million
Q2 2023

Aug 14, 2023

SELL
$8.53 - $14.28 $847,864 - $1.42 Million
-99,398 Reduced 45.32%
119,918 $1.35 Million
Q1 2023

May 15, 2023

BUY
$10.88 - $15.0 $2.31 Million - $3.18 Million
212,167 Added 2967.79%
219,316 $2.53 Million
Q4 2022

Feb 14, 2023

BUY
$9.37 - $13.8 $66,986 - $98,656
7,149 New
7,149 $82,000
Q1 2022

May 16, 2022

SELL
$6.52 - $12.27 $685,930 - $1.29 Million
-105,204 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$11.89 - $16.07 $1.43 Million - $1.93 Million
-119,879 Reduced 53.26%
105,204 $1.25 Million
Q3 2021

Nov 15, 2021

SELL
$15.6 - $21.46 $2.26 Million - $3.1 Million
-144,631 Reduced 39.12%
225,083 $3.66 Million
Q2 2021

Aug 17, 2021

SELL
$15.94 - $22.33 $1.28 Million - $1.79 Million
-80,350 Reduced 17.85%
369,714 $7.78 Million
Q1 2021

May 17, 2021

BUY
$14.0 - $29.3 $4.9 Million - $10.3 Million
350,064 Added 350.06%
450,064 $6.99 Million
Q4 2020

Feb 16, 2021

BUY
$16.81 - $23.94 $504,299 - $718,200
30,000 Added 42.86%
100,000 $2.1 Million
Q3 2020

Nov 12, 2020

BUY
$20.0 - $23.9 $1.4 Million - $1.67 Million
70,000 New
70,000 $1.41 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.